ArticleCancer medicine2019

IL-25 promotes cisplatin resistance of lung cancer cells by activating NF-κB signaling pathway to increase of major vault protein.

Weiming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.